Skip to main content
AmigoFish

Episode 536 - Uromigos Live 2026 – High-risk Localized Prostate Cancer

From The Uromigos · · 48 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Several phase 3 trials in high-risk localized prostate cancer have reported this year including PROTEUS and DASL. The panel debates if and how these will impact treatment of this patient population.

Back to The Uromigos · Report a problem